Skip to main content
Clinical Trials/RBR-2fm8j9
RBR-2fm8j9
Active, not recruiting
未知

Role of the Intestinal Microbiota for management of Metabolic syndrome and Obesity - : Clinics Hospital of Univesity of Sao Paulo

Faculdade de Medicina da Universidade São Paulo0 sitesOctober 22, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
obesity
Sponsor
Faculdade de Medicina da Universidade São Paulo
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention
Sex
Female

Investigators

Sponsor
Faculdade de Medicina da Universidade São Paulo

Eligibility Criteria

Inclusion Criteria

  • Receivers: Caucasian women between the ages of 18 and 60 with a Body Mass Index (BMI) between 30 and 40 kg / m2 \- obesity grade I and II \- who meet the 2005 International Diabetes Federation (IDF) criteria for metabolic syndrome.

Exclusion Criteria

  • Receptors: patients with comorbidities that may interfere with data evaluation, use medications for metabolic syndrome, use antibiotics / pro\-biotics in the past 90 days, previous cholecystectomy surgery, or have recent weight changes. Patients who refuse to participate in the study or who do not sign any of the terms of consent will also be excluded.
  • Donors: donors who have received antibiotics for the last three months, who have risky sexual behavior

Outcomes

Primary Outcomes

Not specified

Similar Trials